Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Yasmeen Abouelhassan, PhD
Associate Director, QP2
Merck & Co Inc
Poster(s):
079: Exploring the Impact of Hepatic Impairment on the Pharmacokinetics of New Molecular Entities: A Comprehensive Analysis of Labeling Information
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
